Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD)

IF 3.7 2区 医学 Q1 RHEUMATOLOGY Lupus Science & Medicine Pub Date : 2024-07-01 DOI:10.1136/lupus-2024-001213
Jessica Ellis, Neil McHugh, John D Pauling, Ian N Bruce, Rachel Charlton, Anita McGrogan, Sarah Skeoch
{"title":"Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD)","authors":"Jessica Ellis, Neil McHugh, John D Pauling, Ian N Bruce, Rachel Charlton, Anita McGrogan, Sarah Skeoch","doi":"10.1136/lupus-2024-001213","DOIUrl":null,"url":null,"abstract":"Objective To obtain updated estimates on the incidence and prevalence of systemic lupus erythematosus (SLE) in the UK, over the period 1990–2020, using the Clinical Practice Research Datalink (CPRD). Methods This was a retrospective cohort study using the CPRD covering the period 1990–2020. A case ascertainment algorithm was developed in line with best practice recommendations for observational research. Incidence was calculated per 100 000 person-years and point prevalence (at the mid-year point) calculated per 100 000. Results were stratified by sex. Results 9443 SLE cases were identified. 5278 incident cases were identified (4538 women, 740 men). The overall incidence rate was 5.47 (95% CI 5.33 to 5.62) cases per 100 000 person-years. Incidence rates decreased slightly across the study period, which was more pronounced for women than men. Point prevalence increased over time, from 21.4 (95% CI 17.68 to 25.67) per 100 000 in 1990 to 107.14 (95% CI 103.26 to 111.12) per 100 000 in 2020. Conclusions The observed fivefold increase in prevalence of SLE over the last 30 years, in the context of a modest decline in incidence rate, may suggest improved outcomes in SLE and has important implications for healthcare service delivery and planning in the UK. Data are available upon reasonable request. The data underlying this article were provided by Clinical Practice Research Datalink under license. Available data will be shared on request to the corresponding author with permission of the Clinical Practice Research Datalink.","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"27 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lupus Science & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/lupus-2024-001213","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To obtain updated estimates on the incidence and prevalence of systemic lupus erythematosus (SLE) in the UK, over the period 1990–2020, using the Clinical Practice Research Datalink (CPRD). Methods This was a retrospective cohort study using the CPRD covering the period 1990–2020. A case ascertainment algorithm was developed in line with best practice recommendations for observational research. Incidence was calculated per 100 000 person-years and point prevalence (at the mid-year point) calculated per 100 000. Results were stratified by sex. Results 9443 SLE cases were identified. 5278 incident cases were identified (4538 women, 740 men). The overall incidence rate was 5.47 (95% CI 5.33 to 5.62) cases per 100 000 person-years. Incidence rates decreased slightly across the study period, which was more pronounced for women than men. Point prevalence increased over time, from 21.4 (95% CI 17.68 to 25.67) per 100 000 in 1990 to 107.14 (95% CI 103.26 to 111.12) per 100 000 in 2020. Conclusions The observed fivefold increase in prevalence of SLE over the last 30 years, in the context of a modest decline in incidence rate, may suggest improved outcomes in SLE and has important implications for healthcare service delivery and planning in the UK. Data are available upon reasonable request. The data underlying this article were provided by Clinical Practice Research Datalink under license. Available data will be shared on request to the corresponding author with permission of the Clinical Practice Research Datalink.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
1990年至2020年间系统性红斑狼疮发病率和流行率的变化:利用临床实践研究数据链(CPRD)进行的观察研究
目的 利用临床实践研究数据链接(CPRD)获得 1990-2020 年间英国系统性红斑狼疮(SLE)发病率和流行率的最新估计值。方法 这是一项利用 CPRD 进行的回顾性队列研究,时间跨度为 1990-2020 年。根据观察性研究的最佳实践建议制定了病例确定算法。发病率按每 10 万人年计算,点流行率(年中点)按每 10 万人计算。结果按性别进行了分层。结果 共发现 9443 例系统性红斑狼疮病例。其中发现了 5278 例发病病例(女性 4538 例,男性 740 例)。总发病率为每 10 万人年 5.47 例(95% CI 5.33 至 5.62)。在整个研究期间,发病率略有下降,女性比男性更为明显。随着时间的推移,点流行率从 1990 年的每 10 万人 21.4 例(95% CI 17.68 至 25.67 例)上升到 2020 年的每 10 万人 107.14 例(95% CI 103.26 至 111.12 例)。结论 在发病率略有下降的背景下,我们观察到系统性红斑狼疮的患病率在过去30年中增长了5倍,这可能表明系统性红斑狼疮的治疗效果有所改善,对英国的医疗服务提供和规划具有重要意义。如有合理要求,可提供相关数据。本文所依据的数据由临床实践研究数据链(Clinical Practice Research Datalink)授权提供。经临床实践研究数据链(Clinical Practice Research Datalink)许可,可向通讯作者索取并分享现有数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Lupus Science & Medicine
Lupus Science & Medicine RHEUMATOLOGY-
CiteScore
5.30
自引率
7.70%
发文量
88
审稿时长
15 weeks
期刊介绍: Lupus Science & Medicine is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.
期刊最新文献
Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS. Using photovoice to investigate patient experiences of lupus nephritis in Canada. Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis. Improving routine mental health screening for depression and anxiety in a paediatric lupus clinic: a quality improvement initiative for enhanced mental healthcare. Validating claims-based algorithms for a systemic lupus erythematosus diagnosis in Medicare data for informed use of the Lupus Index: a tool for geospatial research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1